INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 45h ago
House PTR5h ago
SEC 13F5h ago
Robinhood Chain5h ago

Results

77,289 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
8
MJ
Murry Stefan J.Chief Financial Officer
AAOIAPPLIED OPTOELECTRONICS, INC.
Tax withholding
F$112K
746 sh
Apr 22, 2026Apr 24, 2026
Page 1079 of 1933
← PrevNext →
traded Apr 22, 2026
+2d
SEC Form 4

Evidence

8
MJ
Murry Stefan J.Chief Financial Officer
AAOIAPPLIED OPTOELECTRONICS, INC.
Tax withholding
F$164K
1,086 sh
Apr 22, 2026Apr 24, 2026
traded Apr 22, 2026
+2dSEC Form 4

Evidence

8
KC
Kuo David C*** See Remarks
AAOIAPPLIED OPTOELECTRONICS, INC.
Tax withholding
F$78K
518 sh
Apr 22, 2026Apr 24, 2026
traded Apr 22, 2026
+2dSEC Form 4

Evidence

8
KC
Kuo David C*** See Remarks
AAOIAPPLIED OPTOELECTRONICS, INC.
Tax withholding
F$85K
567 sh
Apr 22, 2026Apr 24, 2026
traded Apr 22, 2026
+2dSEC Form 4

Evidence

8
MJ
Murry Stefan J.Chief Financial Officer
AAOIAPPLIED OPTOELECTRONICS, INC.
Tax withholding
F$127K
846 sh
Apr 22, 2026Apr 24, 2026
traded Apr 22, 2026
+2dSEC Form 4

Evidence

6
GC
Gibson ChristopherDirector
RXRXRECURSION PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$144K
40.0K sh
Apr 22, 2026Apr 24, 2026
traded Apr 22, 2026
+2dSEC Form 4

Evidence

5
BT
Boersma TravisDirector, Executive Chairman of Board, 10% Owner
BROSDutch Bros Inc.
Other acquisition or disposition
J—
19.3K sh
Apr 22, 2026Apr 24, 2026
traded Apr 22, 2026
+2dSEC Form 4

Evidence

5
BT
Boersma TravisDirector, Executive Chairman of Board, 10% Owner
BROSDutch Bros Inc.
Other acquisition or disposition
J—
13.3K sh
Apr 22, 2026Apr 24, 2026
traded Apr 22, 2026
+2dSEC Form 4

Evidence

5
DA
DM Trust Aggregator, LLC10% Owner
BROSDutch Bros Inc.
Other acquisition or disposition
J—
19.3K sh
Apr 22, 2026Apr 24, 2026
traded Apr 22, 2026
+2dSEC Form 4

Evidence

5
KT
Kunkel Julie T.Director
BLMNBloomin' Brands, Inc.
Option exercise
M—
19.7K sh
Apr 22, 2026Apr 24, 2026
traded Apr 22, 2026
+2dSEC Form 4

Evidence

5
DA
DM Trust Aggregator, LLC10% Owner
BROSDutch Bros Inc.
Other acquisition or disposition
J—
27.3K sh
Apr 22, 2026Apr 24, 2026
traded Apr 22, 2026
+2dSEC Form 4

Evidence

5
BT
Boersma TravisDirector, Executive Chairman of Board, 10% Owner
BROSDutch Bros Inc.
Other acquisition or disposition
J—
27.3K sh
Apr 22, 2026Apr 24, 2026
traded Apr 22, 2026
+2dSEC Form 4

Evidence

5
AN
Abrahamsen Danielle NicoleChief Accounting Officer
CVLTCOMMVAULT SYSTEMS INC
Grant or award
A—
1,258 sh
Apr 22, 2026Apr 24, 2026
traded Apr 22, 2026
+2dSEC Form 4

Evidence

5
BT
Boersma TravisDirector, Executive Chairman of Board, 10% Owner
BROSDutch Bros Inc.
Other acquisition or disposition
J—
670 sh
Apr 22, 2026Apr 24, 2026
traded Apr 22, 2026
+2dSEC Form 4

Evidence

5
KT
Kunkel Julie T.Director
BLMNBloomin' Brands, Inc.
Grant or award
A—
23.5K sh
Apr 22, 2026Apr 24, 2026
traded Apr 22, 2026
+2dSEC Form 4

Evidence

5
DA
DM Individual Aggregator, LLC10% Owner
BROSDutch Bros Inc.
Other acquisition or disposition
J—
13.3K sh
Apr 22, 2026Apr 24, 2026
traded Apr 22, 2026
+2dSEC Form 4

Evidence

5
DA
DM Individual Aggregator, LLC10% Owner
BROSDutch Bros Inc.
Other acquisition or disposition
J—
17.2K sh
Apr 22, 2026Apr 24, 2026
traded Apr 22, 2026
+2dSEC Form 4

Evidence

5
BT
Boersma TravisDirector, Executive Chairman of Board, 10% Owner
BROSDutch Bros Inc.
Other acquisition or disposition
J—
17.2K sh
Apr 22, 2026Apr 24, 2026
traded Apr 22, 2026
+2dSEC Form 4

Evidence

5
BT
Boersma TravisDirector, Executive Chairman of Board, 10% Owner
BROSDutch Bros Inc.
Other acquisition or disposition
J—
427 sh
Apr 22, 2026Apr 24, 2026
traded Apr 22, 2026
+2dSEC Form 4

Evidence

4
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Open-market sale · 10b5-1 plan
SELL$262K
19.1K sh
Apr 23, 2026Apr 24, 2026
traded Apr 23, 2026
+1dSEC Form 4

Evidence

4
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Open-market sale · 10b5-1 plan
SELL$267K
19.1K sh
Apr 24, 2026Apr 24, 2026
traded Apr 24, 2026
+0dSEC Form 4

Evidence

3
OC
O'Hara John CharlesDirector, Chief Financial Officer
LAESSEALSQ Corp
Open-market sale · 10b5-1 plan
SELL$15K
5,250 sh
Apr 24, 2026Apr 24, 2026
traded Apr 24, 2026
+0dSEC Form 4

Evidence

3
OC
O'Hara John CharlesDirector, Chief Financial Officer
LAESSEALSQ Corp
Open-market sale · 10b5-1 plan
SELL$31K
10.0K sh
Apr 22, 2026Apr 24, 2026
traded Apr 22, 2026
+2dSEC Form 4

Evidence

3
OC
O'Hara John CharlesDirector, Chief Financial Officer
LAESSEALSQ Corp
Open-market sale · 10b5-1 plan
SELL$29K
10.0K sh
Apr 23, 2026Apr 24, 2026
traded Apr 23, 2026
+1dSEC Form 4

Evidence

0
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
15.4K sh
Apr 22, 2026Apr 24, 2026
traded Apr 22, 2026
+2dSEC Form 4

Evidence

0
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
61.5K sh
Apr 22, 2026Apr 24, 2026
traded Apr 22, 2026
+2dSEC Form 4

Evidence

0
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M$125K
14.7K sh
Apr 22, 2026Apr 24, 2026
traded Apr 22, 2026
+2dSEC Form 4

Evidence

0
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M—
14.7K sh
Apr 24, 2026Apr 24, 2026
traded Apr 24, 2026
+0dSEC Form 4

Evidence

0
GC
Gibson ChristopherDirector
RXRXRECURSION PHARMACEUTICALS, INC.
Derivative conversion · 10b5-1 plan
C—
40.0K sh
Apr 22, 2026Apr 24, 2026
traded Apr 22, 2026
+2dSEC Form 4

Evidence

0
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M—
14.7K sh
Apr 23, 2026Apr 24, 2026
traded Apr 23, 2026
+1dSEC Form 4

Evidence

0
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M$125K
14.7K sh
Apr 23, 2026Apr 24, 2026
traded Apr 23, 2026
+1dSEC Form 4

Evidence

0
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M$125K
14.7K sh
Apr 24, 2026Apr 24, 2026
traded Apr 24, 2026
+0dSEC Form 4

Evidence

0
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
61.5K sh
Apr 22, 2026Apr 24, 2026
traded Apr 22, 2026
+2dSEC Form 4

Evidence

0
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
15.4K sh
Apr 22, 2026Apr 24, 2026
traded Apr 22, 2026
+2dSEC Form 4

Evidence

0
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M—
14.7K sh
Apr 22, 2026Apr 24, 2026
traded Apr 22, 2026
+2dSEC Form 4

Evidence

0
GC
Gibson ChristopherDirector
RXRXRECURSION PHARMACEUTICALS, INC.
Derivative conversion · 10b5-1 plan
C—
40.0K sh
Apr 22, 2026Apr 24, 2026
traded Apr 22, 2026
+2dSEC Form 4

Evidence

44
HD
Hoag Erik DChief Financial Officer
TNLTravel & Leisure Co.
Open-market purchase
BUY$66K
1,000 sh
Apr 23, 2026Apr 23, 2026
traded Apr 23, 2026
+0dSEC Form 4

Evidence

44
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$1.43M
12.1K sh
Apr 21, 2026Apr 23, 2026
traded Apr 21, 2026
+2dSEC Form 4

Evidence

43
SS
Sharma SanjaySee Remarks*
SEICSEI INVESTMENTS CO
Open-market sale
SELL$2.11M
23.4K sh
Apr 23, 2026Apr 23, 2026
traded Apr 23, 2026
+0dSEC Form 4

Evidence

41
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$388K
3,255 sh
Apr 21, 2026Apr 23, 2026
traded Apr 21, 2026
+2dSEC Form 4

Evidence